Skip to main content
Premium Trial:

Request an Annual Quote

CompanionDx to Expand NGS Offerings with Thermo Fisher Cancer Assays

NEW YORK (GenomeWeb) – CompanionDx, a high-complexity CLIA-certified laboratory, announced on Monday that it will expand its next-generation sequencing (NGS) offerings with two of Thermo Fisher Scientific cancer assays. 

CompanionDx said it will provide the Oncomine Focus Assay and the Oncomine Comprehensive Assay to clients performing studies across a range of different cancer types. The deal creates new NGS services that could be used in combination with pharmacogenomics to facilitate drug development and clinical research program by drug manufacturers, CompanionDx said. 

Both assays are based on Thermo Fisher's Ion AmpliSeq technology, and allow for the detection of single nucleotide somatic changes, inversions, insertions, and deletions, as well as gene fusions and copy number variations, CompanionDx said. 

The Oncomine Focus is designed for translational and clinical research, and includes 52 solid tumor genes associated with existing cancer drugs and published data, the company added. The Oncomine Comprehensive enables analysis of a broader set of genes deemed relevant to published clinical trials. 

"The Oncomine Focus and Oncomine Comprehensive Assays offer powerful NGS-based solutions for detection of relevant genes in a simplified workflow," Mike Nolan, vice president and general manager of oncology for Thermo Fisher, said in a statement. He added that in combination with Thermo Fisher's Applied Biosystems real-time pharmacogenomics solution, "these sophisticated tools further expand the capability of labs aiming to assist drug development research." 

CompanionDx said it expects to make NGS services incorporating the assays available by the end of the second quarter.

The Scan

Genetic Ancestry of South America's Indigenous Mapuche Traced

Researchers in Current Biology analyzed genome-wide data from more than five dozen Mapuche individuals to better understand their genetic history.

Study Finds Variants Linked to Diverticular Disease, Presents Polygenic Score

A new study in Cell Genomics reports on more than 150 genetic variants associated with risk of diverticular disease.

Mild, Severe Psoriasis Marked by Different Molecular Features, Spatial Transcriptomic Analysis Finds

A spatial transcriptomics paper in Science Immunology finds differences in cell and signaling pathway activity between mild and severe psoriasis.

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.